Influence of naloxone on the postoperative analgesic and respiratory effects of buprenorphine

Overview of attention for article published in European Journal of Clinical Pharmacology, July 1988

Altmetric Badge

Mentioned by

patent: 52 patents

Readers on

mendeley: 23 Mendeley

Summary Patents

So far, Altmetric has seen 52 patents that reference this research output.

Tamper resistant oral opioid agonist formulations

Grant US-10588865-B2

United States of America

17 Mar 2020

Pharmaceutical preparation containing oxycodone and naloxone

Grant US-10420762-B2

United States of America

24 Sep 2019

Tamper resistant oral opioid agonist formulations

Grant US-10350173-B2

United States of America

16 Jul 2019

Method and device for the assessment of bowel function

Grant US-10258235-B2

United States of America

16 Apr 2019

Combination of oxycodone and naloxone for use in treating pain in patients suffering from…

Grant US-10071089-B2

United States of America

11 Sep 2018

Pharmaceutical preparation containing oxycodone and naloxone

Grant US-9907793-B2

United States of America

06 Mar 2018

Buprenorphine-wafer for drug substitution therapy

Grant US-9861628-B2

United States of America

09 Jan 2018

Immediate release pharmaceutical compositions comprising oxycodone and naloxone

Grant US-9820983-B2

United States of America

21 Nov 2017

Tamper resistant oral opioid agonist formulations

Grant US-9801828-B2

United States of America

31 Oct 2017

Buprenorphine-wafer for drug substitution therapy

Grant US-9763931-B2

United States of America

19 Sep 2017

Matrix for sustained, invariant and independent release of active compounds

Grant US-9655855-B2

United States of America

23 May 2017

Pharmaceutical preparation containing oxycodone and naloxone

Grant US-9555000-B2

United States of America

31 Jan 2017

Abuse-resistant controlled-release opioid dosage form

Grant US-9511066-B2

United States of America

06 Dec 2016

Abuse-resistant controlled-release opioid dosage form

Grant US-9480685-B2

United States of America

01 Nov 2016

Tamper-resistant oral opioid agonist formulations

Grant US-9456989-B2

United States of America

04 Oct 2016

Buprenorphine-wafer for drug substitution therapy

Grant US-9370512-B2

United States of America

21 Jun 2016

Abuse-resistant controlled-release opioid dosage form

Grant US-9358230-B1

United States of America

07 Jun 2016

Abuse-resistant controlled-release opioid dosage form

Grant US-9345701-B1

United States of America

24 May 2016

Abuse-resistant controlled-release opioid dosage form

Grant US-9283221-B2

United States of America

15 Mar 2016

Abuse-resistant controlled-release opioid dosage form

Grant US-9283216-B2

United States of America

15 Mar 2016

Tamper-resistant oral opioid agonist formulations

Grant US-9278073-B2

United States of America

08 Mar 2016

Immediate release pharmaceutical compositions comprising oxycodone and naloxone

Grant US-9271940-B2

United States of America

01 Mar 2016

Opioid agonist/antagonist combinations

Grant US-9205082-B2

United States of America

08 Dec 2015

Abuse-resistant controlled-release opioid dosage form

Grant US-9168252-B2

United States of America

27 Oct 2015

Abuse-resistant controlled-release opioid dosage form

Grant US-9161937-B2

United States of America

20 Oct 2015

Buprenorphine-wafer for drug substitution therapy

Grant US-9101625-B2

United States of America

11 Aug 2015

Abuse-resistant controlled-release opioid dosage form

Grant US-9084729-B2

United States of America

21 Jul 2015

Abuse-resistant controlled-release opioid dosage form

Grant US-9056051-B2

United States of America

16 Jun 2015

Abuse-resistant controlled-release opioid dosage form

Grant US-8969369-B2

United States of America

03 Mar 2015

Tamper-resistant oral opioid agonist formulations

Grant US-8936812-B2

United States of America

20 Jan 2015

Opioid agonist/antagonist combinations

Grant US-8932630-B1

United States of America

13 Jan 2015

Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist…

Application US-8877247-B2

United States of America

04 Nov 2014

Matrix for sustained, invariant and independent release of active compounds

Grant US-8846090-B2

United States of America

30 Sep 2014

Pharmaceutical compositions for the deterrence and/or prevention of abuse

Application US-8846104-B2

United States of America

30 Sep 2014

Matrix for sustained, invariant and independent release of active compounds

Grant US-8846091-B2

United States of America

30 Sep 2014

Sequestering subunit and related compositions and methods

Application US-8685443-B2

United States of America

01 Apr 2014

Sequestering subunit and related compositions and methods

Application US-8685444-B2

United States of America

01 Apr 2014

Pharmaceutical composition

Application US-8623418-B2

United States of America

07 Jan 2014

Tamper-resistant oral opioid agonist formulations

Grant US-8586088-B2

United States of America

19 Nov 2013

Opioids for the treatment of the chronic obstructive pulmonary disease (COPD)

Grant US-8518925-B2

United States of America

27 Aug 2013

Tamper-resistant oral opioid agonist formulations

Grant US-8357399-B2

United States of America

22 Jan 2013

Tamper-resistant oral opioid agonist formulations

Grant US-8236351-B2

United States of America

07 Aug 2012

Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist…

Application US-8158156-B2

United States of America

17 Apr 2012

Tamper-resistant oral opioid agonist formulations

Grant US-7842311-B2

United States of America

30 Nov 2010

Tamper-resistant oral opioid agonist formulations

Grant US-7842309-B2

United States of America

30 Nov 2010

Tamper-resistant oral opioid agonist formulations

Grant US-7718192-B2

United States of America

18 May 2010

Pharmaceutical composition

Application US-7682633-B2

United States of America

23 Mar 2010

Tamper-resistant oral opioid agonist formulations

Grant US-7682632-B2

United States of America

23 Mar 2010

Pharmaceutical compositions

Application US-7682634-B2

United States of America

23 Mar 2010

Tamper-resistant oral opioid agonist formulations

Grant US-7658939-B2

United States of America

09 Feb 2010

Tamper-resistant oral opioid agonist formulations

Application US-6696088-B2

United States of America

24 Feb 2004

Opioid agonist/antagonist combinations

Grant US-6696066-B2

United States of America

24 Feb 2004